Fa-ChyiLeeMD

Oncology • Orange, CA

Professor, Department of Internal Medicine Chief, Section of Gastrointestinal Oncology, Department of Internal Medicine University of New Mexico Cancer Center

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lee's full profile

Already have an account?

Office
200 S Manchester
Orange, CA 92868
Is this information wrong?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1991 - 1994
Saint Louis University School of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 1993 - 2025
NM State Medical License 1999 - 2018
TX State Medical License 1997 - 2004

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014

Clinical Trials

Combination Paclitaxel, Carboplatin and Temozolomide Start of enrollment: 2003 Nov 01
Completed
Phase 1
Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer Start of enrollment: 2005 Apr 01
Terminated
Phase 2
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma Start of enrollment: 2000 Sep 01
Completed
Phase 1, Phase 2
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib Start of enrollment: 2005 Nov 01
Terminated
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer Start of enrollment: 2006 Sep 01
Terminated
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review Start of enrollment: 2006 Feb 01
Terminated
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers Start of enrollment: 2008 Nov 01
Terminated
Not Applicable
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2008 Oct 01
Completed
Phase 2
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Completed
Phase 2
Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers Start of enrollment: 2015 Nov 01
Withdrawn
Phase 2
Join now to see all

Publications & Presentations

PubMed

A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with g...
Yazdanpanah, O., Lee, F., Houshyar, R., Nourbakhsh, M., Mar, N.> ;SAGE Open Medical Case Reports. 2024 Jan 1
Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiation.
Grant, C., Truc, T., Arter, Z., Lee, F.> ;Frontiers in Oncology. 2023 Jan 1
1 citations
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy.
Dalia Kaakour, Garo Hagopian, Sonia Lee, Fa Chyi Lee> ;American Journal of Clinical Oncology. 2022 Oct 1
8 citations
-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms.
Naomie Devico Marciano, Gianna Kroening, Farshid Dayyani, Jason A Zell, Fa-Chyi Lee, May Cho, Jennifer Goldstein Valerin> ;Cancers. 2022 May 16
10 citations
Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems
Divya Ahuja Parikh, Meera Vimala Ragavan, Ritika Dutta, Jeffrey Edwards, James Dickerson, Debeshi Maitra, Sangeeta Aggarwal, Fa-Chyi Lee, Manali I. Patel> ;JCO Oncology Practice. 2021 Apr 7
8 citations
Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check.
Amy C. H. Lee, Fa-Chyi Lee> ;Frontiers of Medicine. 2020 Jun 8
Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer.
Fa-Chyi Lee> ;JAMA Oncology. 2020 Apr 1
37 citations
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Can...
Aparna Raj Parikh, Fa-Chyi Lee, Linda Yau, Han Koh, James A. Knost, Edith P. Mitchell, Ivan Bosanac, Nicholas Choong, Frank A. Scappaticci, Christoph Mancao, Heinz-Jos...> ;Clinical Cancer Research. 2019 May 15
19 citations
90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;European Journal of Cancer. 2015 Sep 1
24 citations
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.
Julie E. Bauman, Monte Shaheen, Claire F. Verschraegen, Steven A. Belinsky, M. Houman Fekrazad, Fa-Chyi Lee, Ian Rabinowitz, Meera Ravindranathan, Dennie V. Jones> ;Translational Oncology. 2014 Jun 1
7 citations
Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature
Waheed Murad, Ian Rabinowitz, Fa-Chyi Lee> ;ACG Case Reports Journal. 2014 Jan 10
6 citations
Longterm clinical remission of oral and cutaneous pemphigus with thalidomide.
Fa-Chyi Lee> ;International Journal of Dermatology. 2011 Sep 1
8 citations
Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery
Hoan Tran, Rafael Medina-Flores, Lisa A. Cerilli, Jeremy Phelps, Fa-Chyi Lee, Gene Wong, Paul Turner> ;Journal of Neuro-Oncology. 2010 Mar 30
46 citations
Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
Fa-Chyi Lee, Shakil H. Merchant> ;American Journal of Hematology. 2003 May 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

UCI HealthOrange, California